Jeannie Chern, MD, discusses challenges with germline molecular testing for patients with ovarian cancer.
Jeannie Chern, MD
Advertisement
Articles by Jeannie Chern, MD
Jeannie Chern, MD, a gynecologic oncologist at Moffitt Cancer Center, discusses important germline and somatic mutations to be aware of in ovarian cancer.
Advertisement
Latest Updated Articles
Dr. Chern on Important Germline and Somatic Mutations in Ovarian CancerFebruary 17th 2020
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
3
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
4
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
5